Election 2012
Full Speed Ahead on ObamaCare
With the Presidential election decided and President Obama the clear winner, it’s time for pharma to get down to business on the implementation of ObamaCare. Here are some of the key actions to anticipate between now and January 1, 2013 ...Read more
Advertisement
Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the “quality” of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using  Case Quality Metrics while working with large and small pharmaceutical companies.
Contact Email:ask@sciformix.com |
Forecast
Poor 2012 for Pharma, But Signs of Hope in 2013
The long-awaited patent cliff that has loomed over the pharma industry for years arrived in earnest in 2012, with more than $40 billion in 2011 brand sales facing loss of exclusivity (LOE). But there are some hopeful signs for 2013, writes Andrew Forman
...Read More
Advertisement
Pharmaceutical sales organizations navigate several challenges in today's dynamic markets: volatile sales portfolios, changing managed care contracts, and impaired physician access. Learn 4 key reasons why you need a dynamic alignment management system for today's marketplace.  Download today! |
Special Report
Pharmacists: The Other White Coats
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence, writes Ben Comer
...Read more
Advertisement
Brand: Going Beyond Single-Mindedness
Live Webcast: Thursday, November 8, 2012 from 2:00 PM - 3:00 PM EST
Register Free at  www.pharmexec.com/single |
Global
IP Climate Change: Patent Rights Face Headwinds
The pharma industry has faced a growing movement against patent protection in favor of providing access to low cost medicines, specifically in developing countries, writes Clark Herman
...Read more
Advertisement
Engaging Oncology Providers: What Works?
Live Webcast: Wednesday, November 14, 2012 at 11:00 AM EST
Register Free at  www.pharmexec.com/whatworks |
Technology
Time to Create a Mobile App?
If we swallow the hype and decide that we all need to get onto the mobile app bandwagon, how exactly do we go about it? Sven Awege explains
...Read more
|
|
|
 // PHT Corporation (Boston, MA) announced the appointment of Dr. Susan Dallabrida as Senior Scientific Advisor. // New Jersey-based Carlo Truppi joined UK firm Penn Pharma as US Business Development Manager. // Hettie Han rejoined Kantar Health (New York, NY), as Director, Kantar Health China. She will be based in Beijing, China.
// Teva Americas Generics (North Wales, PA) named Allan Oberman as President and Chief Executive. Teva also announced the appointment of Jill DeSimone to the newly created position of Senior VP and General Manager of Teva Global Women’s Health. |
|
